Clinical Evolution of a Cohort of Patients with COVID-19 Treated with Usual Medical Care Plus Polymerized Type I Collagen During the Pandemic Emergency
PTIC significantly improved clinical parameters in patients with COVID-19. It improves oxygen saturation levels, decreases the need for supplemental oxygen, and improves survival compared to patients who are not treated with PTIC. Additional studies are needed to validate the use of PTIC as an adjunctive therapy for patients with COVID-19.
Authors
- Aurelio Perez-Favila (ORCID: https://orcid.org/0000-0002-3343-3764)
- Margarita L. Martinez-Fierro
- Edgar Fernando Gutierrez-Vela
- Ana Gabriela Castañeda-Miranda (ORCID: https://orcid.org/0000-0003-0138-6390)
- Lucia Socorro Hernandez-Marquez
- Maria Calixta Martínez-Vázquez
- Celia Elizabeth Luna-Pacheco
- Francisco Luna-Pacheco
- Idalia Garza-Veloz
- Ivan Delgado-Enciso
- Alfredo Salazar de Santiago
Institutions
- Mexican Social Security Institute (MX)
- Universidad Autónoma de Zacatecas "Francisco García Salinas" (MX)
Publication Details
- Journal
- Medical Sciences
- Published
- 2026-03-03
- DOI
- https://doi.org/10.3390/medsci14010118
- Primary Topic
- Dermatological and COVID-19 studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidad Autónoma de Zacatecas